secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-10-08T10:00:40+00:00
Accession:  0001683168-26-007709
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Valion Bio signs $50,000 Third Side Letter with 3i for Series B preferred shares and warrants
--------------------------------------------------------------------------------

- Valion Bio and 3i, LP entered a Third Side Letter on Oct. 7, 2026, for a $50,000 closing under the Series B Preferred Purchase Agreement.
- 3i agreed to purchase 50 Series B Preferred Shares and Series B Warrants for 1,539 common shares at an initial exercise price of $2.5520 per share.
- The shares and warrants were issued under Section 4(a)(2)/Rule 506(b); Item 3.02 reports the unregistered sales of equity securities.
- The Third Side Letter is Exhibit 10.1; closing conditions include Series B conditions, deliverables, price-adjustment notice, and Nasdaq listing compliance.
- 3i previously purchased 13,637 Series C Preferred Shares for $13,637,000 and holds a $16,253,147.10 note plus Note Warrant for 182,129 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826007709/0001683168-26-007709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826007709/valion_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer